| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6095870 | Gastroenterology | 2010 | 10 Pages |
Abstract
Tumors from Amsterdam-positive patients without mismatch repair deficiency (MSS HNPCC) have certain molecular features, including global hypomethylation, that distinguish them from all other colorectal cancers. These characteristics could have an important impact on tumor behavior or treatment response. Studies are underway to further assess the cause and effects of these features.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ajay Goel, Rosa M. Xicola, Thuy-Phuong Nguyen, Brian J. Doyle, Vanessa R. Sohn, Prathap Bandipalliam, Laura S. Rozek, Josep Reyes, Carmen Cordero, Francesc Balaguer, Antoni Castells, Rodrigo Jover, Montserrat Andreu, Sapna Syngal, C. Richard Boland,